ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
ProQR Therapeutics N.V. - Ordinary Shares (PRQR)
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
proqr.com
Company Research
Source: GlobeNewswire
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will host a virtual Investor and Analyst Event highlighting its pipeline entitled: “Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810” Ahead of the anticipated target engagement data for AX-0810 in the first half of 2026, the Company will showcase ProQR’s broader RNA editing pipeline at this event, announce new programs that will have clinical data readouts in the runway, and unveil the primary indication for AX-0810. Event Details and Registration Title: Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810Date & Time: April 8, 2026 beginning at 10:00 am ET until approximately 11:30 am ETVirtual format: Webcast presentations and Q&A with covering analysts and ManagementRegis
Show less
Read more
Impact Snapshot
Event Time:
PRQR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRQR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRQR alerts
High impacting ProQR Therapeutics N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRQR
News
- ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- ProQR Therapeutics (PRQR) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $9.00 price target on the stock.MarketBeat
- ProQR Announces Year End 2025 Operating and Financial Results [Yahoo! Finance]Yahoo! Finance
- ProQR Announces Year End 2025 Operating and Financial ResultsGlobeNewswire
- Faron Pharmaceuticals Oy (FPHAF) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
PRQR
Earnings
- 11/6/25 - In-Line
PRQR
Analyst Actions
- 3/12/26 - Oppenheimer Holdings, Inc.
PRQR
Sec Filings
- 3/25/26 - Form 6-K
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- PRQR's page on the SEC website